In this issue of the ARLG newsletter, results of the CRACKLE-2 Study are highlighted. Also featured is Larissa Grigoryan, MD, PhD, who received an Early Stage Investigator ...

Read our January issue to learn about the National Institute of Allergy and Infectious Diseases (NIAID) renewal funding of up to $102.5M for the ARLG. In this issue, we also spotlight early-stage investigator, ...

Our September 2019 newsletter includes information about the MASTER-GC Study and the Pharmacokinetics Special Emphasis Panel. We also provide a spotlight on early-career trialist, Thomas L. Holland, MD, MSc ...

Read the April 2019 newsletter to learn more about the Multi-Drug Resistant Organism (MDRO) Network site visits in accordance with the National Institutes of Health (NIH) regulatory compliance ...

Our January 2019 newsletter provides highlights from ARLG at IDWeek 2018^TM, held October 3rd-7th in San Francisco, CA. ARLG leaders, researchers, or committee members moderated panels and presented lectures, posters, or abstracts at close ...

Check out our September 2018 newsletter for our latest fact sheets and lay summaries of results for the RADICAL and PROOF studies.

In this issue, we interview Yohei Doi, MD, ...

The June 2018 newsletter features highlights from our Multi-Drug Resistance Organism (MDRO) global network meeting in Madrid, Spain, as well as an update from the ARLG Mentoring Program.

We also profile ARLG Research ...

Our March 2018 newsletter shares updates from the 2018 ARLG Operations Retreat, as well as highlights the ARLG Special Populations Special Emphasis Panel and the Pediatrics Subcommittee.

You can also learn more about Ritu Banerjee, ...